COMMUNIQUÉ DE PRESSE publié le 06/02/2025 à 07:30, il y a 1 année 2 mois COMPLETION OF THE TRANSACTIONS ANNOUNCED IN DECEMBER 2024 RELATING TO THE AMENDMENT OF THE CONVERTIBLE BONDS SUBSCRIBED BY AN ENTITY AFFILIATED TO HEIGHTS CAPITAL MANAGEMENT, INC. (“HEIGHTS”) AND THE ISSUE OF A SECOND ASSIMILABLE TRANCHE Crossject completes transactions announced in December 2024 related to amendment of convertible bonds subscribed by an entity affiliated to Heights Capital Management, Inc. Second assimilable tranche issued Convertible Bonds Transaction Bond Issue Crossject Heights Capital Management
COMMUNIQUÉ DE PRESSE publié le 06/02/2025 à 07:25, il y a 1 année 2 mois German hotel operator Atomis expands abroad and takes over the renowned Hotel Kaffeemühle in the centre of Austrian capital Vienna - Atomis sets sight on further locations in the neighbouring country German hotel operator Atomis expands abroad by acquiring Hotel Kaffeemühle in Vienna. The 76-room property marks Atomis' first venture outside Germany, with plans for further growth in Austria Expansion Vienna Austria Atomis GmbH Hotel Kaffeemühle
COMMUNIQUÉ DE PRESSE publié le 06/02/2025 à 07:00, il y a 1 année 2 mois Rational AG grows successfully – preliminary figures for the 2024 fiscal year Rational AG reports successful growth with preliminary figures for the 2024 fiscal year, including sales revenue of 1.194 billion euros, EBIT margin of 26.3 percent, and strong performance in America and Europe EBIT Margin Sales Revenue Growth RATIONAL AG 2024 Fiscal Year
COMMUNIQUÉ DE PRESSE publié le 06/02/2025 à 07:00, il y a 1 année 2 mois LPSO Holding Ltd. publishes provisional notice of interim result of the public tender offer for all publicly held registered shares of Orascom Development Holding AG LPSO Holding Ltd. publishes provisional notice of interim result of public tender offer for all publicly held registered shares of Orascom Development Holding AG. Offer includes 87.58% of issued share capital Public Tender Offer Provisional Notice Orascom Development Holding AG Interim Result LPSO Holding Ltd.
COMMUNIQUÉ DE PRESSE publié le 06/02/2025 à 07:00, il y a 1 année 2 mois Acquisitions remain key growth driver for Ringmetall in 2024 Ringmetall SE reports acquisitions as key growth driver for 2024, with revenue up 0.9% to EUR 174.9 million. EBITDA increases by 1.7%. Company met 2024 guidance despite economic challenges Revenue Growth Acquisitions Business Performance Ringmetall SE EBITDA Increase
COMMUNIQUÉ DE PRESSE publié le 06/02/2025 à 07:00, il y a 1 année 2 mois Swiss Prime Site: strong rental growth brings significant increase in earnings in 2024 financial year Swiss Prime Site reports strong rental growth and significant earnings increase in the 2024 financial year due to operational improvements and higher rents Financial Results Real Estate Rental Growth Earnings Increase Swiss Prime Site
COMMUNIQUÉ DE PRESSE publié le 06/02/2025 à 07:00, il y a 1 année 2 mois Aurubis achieves robust operating result in Q1 2024/25Aurubis achieves robust operating result in Q1 2024/25 Aurubis AG reports robust Q1 2024/25 operating result with operating EBT up by 17%. Strategic growth milestones achieved. Outlook confirms strong demand for copper products Aurubis AG Strategic Growth Operating Result Q1 2024/25 Copper Products
COMMUNIQUÉ DE PRESSE publié le 06/02/2025 à 07:00, il y a 1 année 2 mois WashTec AG: Preliminary figures for 2024 WashTec AG exceeds EBIT and ROCE guidance in 2024 preliminary results, with revenue slightly lower. EBIT margin increased to 9.5% Revenue Preliminary Results Fiscal Year 2024 EBIT Margin WashTec AG
COMMUNIQUÉ DE PRESSE publié le 06/02/2025 à 07:00, il y a 1 année 2 mois BIOVERSYS SUCCESSFULLY COMPLETES ITS IPO AT CHF 36 PER SHARE AND STARTS TRADING ON THE SIX SWISS EXCHANGE TOMORROW, FEBRUARY 07, 2025 BioVersys successfully completes its IPO at CHF 36 per share, listing on SIX Swiss Exchange on February 07, 2025. The biopharmaceutical company focuses on antibacterial products against multidrug-resistant bacteria IPO SIX Swiss Exchange Antibacterial Products BioVersys CHF 36
COMMUNIQUÉ DE PRESSE publié le 06/02/2025 à 06:58, il y a 1 année 2 mois ALSO invests sustainably in infrastructure - S/4HANA Introduced in Portugal in February ALSO invests sustainably in infrastructure with the introduction of S/4HANA in Portugal, enhancing efficiency and operational excellence. The state-of-the-art IT ecosystem includes ERP, BI, CRM, WMS, AI, security, data center, and digital platforms Operational Excellence Sustainable Investments IT Infrastructure S/4HANA ALSO
Publié le 07/04/2026 à 16:43, il y a 20 minutes Exercice de l’option de remboursement de l'instrument subordonné FR0010318386
Publié le 07/04/2026 à 16:43, il y a 20 minutes Notice of exercise of early redemption option of the subordinated note ISIN : FR0010318386
Publié le 07/04/2026 à 16:18, il y a 45 minutes NRJ Group - Information relative aux droits de vote au 31.03.2026 (French & English)
Publié le 07/04/2026 à 14:44, il y a 2 heures 19 minutes Statement of transactions in own shares from March 30, 2026 to April 2, 2026
Publié le 07/04/2026 à 15:00, il y a 2 heures 4 minutes Karbon-X Expands Enterprise Climate Platform Through Strategic Partnership with carbon-connect AG
Publié le 07/04/2026 à 14:45, il y a 2 heures 19 minutes Predictiv AI Introduces Clinical AI Reasoning Platform, Files Patent for Domain-Specific Clinical AI Methodology
Publié le 07/04/2026 à 14:40, il y a 2 heures 24 minutes bioEnergy Development Inc. Advances Domestic Activated Carbon Production Worth Up to $30 Million Over 5 Years
Publié le 07/04/2026 à 14:30, il y a 2 heures 34 minutes Measles Rare Pediatric Disease Drug Designation Application Filed for NV-387, PRV Provides for Strong Business Case, Says NanoViricides
Publié le 07/04/2026 à 14:30, il y a 2 heures 34 minutes Sekur Private Data Announces Philip Oakley and Kenneth Rogers as Members of Strategic Advisory Board
Publié le 07/04/2026 à 16:32, il y a 31 minutes Andera Partners portfolio company, Tubulis, acquired by Gilead, adding a potentially best-in-class antibody-drug conjugate and a next-generation platform to Gilead’s oncology pipeline.
Publié le 07/04/2026 à 16:30, il y a 33 minutes From Old Channel to New Garden: How Chaoyang’s 'Sakura River' is Dazzling Spring
Publié le 07/04/2026 à 15:00, il y a 2 heures 4 minutes Amrize Announces Date for First Quarter 2026 Financial Results
Publié le 07/04/2026 à 14:55, il y a 2 heures 8 minutes Original-Research: Delticom AG (von Quirin Privatbank Kapitalmarktgeschäft): Buy
Publié le 07/04/2026 à 14:42, il y a 2 heures 21 minutes Evotec to Receive Approx. $100 Million as Part of Tubulis Acquisition